Nathaniel Jackson

Nathaniel is interested in contributing to potential solutions to control viruses and their spread. As a second year PhD student, he is developing his dissertation and is interested in characterizing virulence factors of viruses and developing recombinant viruses expressing reporter genes to evaluate neutralizing antibodies and antivirals. 

He received a B.S in biochemistry from University of Maryland College Park in 2021, while completing his undergraduate studies, he was research assistant at the Walter Reed Army Institute of Research, contributing to the development of a protein subunit vaccine and monoclonal antibody therapies to treat SARS-CoV-2.